About Zilico
Zilico is a company based in Sheffield (United Kingdom) founded in 2006. Zilico has raised $8.55 million across 2 funding rounds from investors including Deepbridge Capital, Maxhealth Medicine Group and The North West Fund. The company has 15 employees as of December 31, 2020. Zilico operates in a competitive market with competitors including MobileODT, Guided Therapeutics, Illumigyn, Mobidiag and Biop Medical, among others.
- Headquarter Sheffield, United Kingdom
- Employees 15 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zilico Limited
- Date of Incorporation 28 Feb, 2006
- Jurisdiction MANCHESTER
-
Annual Revenue
$62.39 K (USD)79as on Dec 31, 2022
-
Net Profit
-$1.93 M (USD)-23as on Dec 31, 2022
-
EBITDA
-$2 M (USD)-22as on Dec 31, 2022
-
Total Equity Funding
$8.55 M (USD)
in 2 rounds
-
Latest Funding Round
$7 M (USD), Series A
Feb 02, 2018
-
Investors
Deepbridge Capital
& 3 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Zilico
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Zilico
Zilico has successfully raised a total of $8.55M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zilico
Zilico has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Deepbridge Capital, Maxhealth Medicine Group and The North West Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Locked | Locked | Locked | |
|
Venture debt firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Zilico
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zilico
Investment portfolio details for Zilico
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zilico
Detailed financials for Zilico
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zilico Comparisons
Peer comparison for Zilico
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zilico
Zilico operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MobileODT, Guided Therapeutics, Illumigyn, Mobidiag and Biop Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smartphone-based tools for cervical cancer screening are developed.
|
|
| Locked | Locked | Locked |
Light-based devices for cervical cancer diagnostics are developed.
|
|
| Locked | Locked | Locked |
Colonoscope for cervical cancer detection procedures is developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostics for infectious diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostics for cervical cancer are developed.
|
Detailed competitors of Zilico
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zilico
Complete news archive for Zilico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zilico
Zilico was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Zilico is headquartered in Sheffield, United Kingdom. It is registered at Sheffield, England, United Kingdom.
Zilico is a funded company, having raised a total of $8.55M across 2 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Zilico is 15.
Annual revenue of Zilico is $62.39K as on Dec 31, 2022.
Founded in 2006 in Sheffield, United Kingdom, Zilico operates in the medical diagnostics sector, focusing on Electrical Impedance Spectroscopy for cancer detection. Products such as ZedScan are designed for real-time assessment of cervical epithelial tissue during colonoscopy. Two applications are being developed for referral and screening markets. A proof-of-concept study has also been completed using the technology to differentiate oral tissues, including neoplasia.
Zilico's top competitors include Periwinkle Technologies, Guided Therapeutics and Mobidiag.
Zilico has 4 investors. Key investors include Deepbridge Capital, Maxhealth Medicine Group, The North West Fund, and Fusion IP.